销售价格: | ¥ N/A |
商品编号: | AI-0133-0388 |
软件语言: | 英文 |
器械分类: | II |
生产厂家: | Imbio |
公司网址: | https://www.imbio.com/ |
认证信息: | FDA |
系统要求: | Windows |
交付方式: | 下载安装 |
Lung Density Analysis™- Functional
Patented Parametric Response Mapping (PRM) technology
Functional LDA (LDAf) is the only fully-automated image analysis tool providing a complete mapping of normal lung, air-trapping, and areas indicative of emphysema in a combined image to visualize and quantify the components of COPD. LDAf can be useful in assessing other density-evident conditions including BOS, Asthma, and combination diseases as well.
FDA 510(k) Cleared, CE Mark Certified, Health Canada Approved
The Power of Personalized Quantitative Imaging
LDAf offers advanced density analysis for patients with COPD, Asthma, Bronchiolitis Obliterans Syndrome, and other conditions. LDAf provides maximum information for personalized care decisions as well as surgical and interventional procedure planning.
Differentiate Your Patients and Customize Their TreatmentsHere are four paients with the same standard clinical assessments. LDAf provides data to: 1. Determine what specific lung regions are affected2. Assess how diffuse (homogenous) or concentrated (heterogeneous) is the disease. 3. Phenotype just how much potential ful-fledgedemphysema there is vs.air-trapping
LDAf Physician Summary Report
Advanced COPD analysis for advanced personalized care decisions. Each LDAf report includes: 1. Coronal, axial and sagital midine slicevisuals. 2. Quick-read bar chart of total normal lung vs. COPD sub-components. 3. Detalled quanitative data of low densities by lung regions(lung lobes or thirds optional) 4.inspiratory and expiratory lung volumes.
Automated Inspiration-Expiration Processing
Clear visualization of normal lung versus areas indicative of air trapping & emphysema
For Your Practice
LDAf is a fully automated solution delivering full quantitative analysis and 3D visualization without added work for Radiology.
Suggested use cases for LDAf
Situations where pulmonary testing (PFT’s) are inconclusivei.e. normal PFT’s, yet symptomatic patient
Surgical or interventional patient selection and procedure planningi.e. fully identify the location and extent of damage, best navigational route, screen out contra-indications, etc.
Determining “tipping points” for changing course of carei.e. change from medical to surgical interventional care, or treating potential emphysema versus air-trapping
Anytime clinicians would like to more fully understand their patient – a more personalized, comprehensive picture of lung function
Clinical Trials and Research
Lung Health programs
非常抱歉,您只有购买软件后才能查看完整软件教程!